DK1242436T3 - Oligosaccharidblanding - Google Patents

Oligosaccharidblanding

Info

Publication number
DK1242436T3
DK1242436T3 DK00983244T DK00983244T DK1242436T3 DK 1242436 T3 DK1242436 T3 DK 1242436T3 DK 00983244 T DK00983244 T DK 00983244T DK 00983244 T DK00983244 T DK 00983244T DK 1242436 T3 DK1242436 T3 DK 1242436T3
Authority
DK
Denmark
Prior art keywords
oligosaccharides
oligosaccharide
extracted
animal
oligosaccharide mixture
Prior art date
Application number
DK00983244T
Other languages
Danish (da)
English (en)
Inventor
Gilda Georgi
Bernd Stahl
Guenther Boehm
Berndt Finke
Juergen Jelinek
Joachim J Schmitt
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7931729&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1242436(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK1242436T3 publication Critical patent/DK1242436T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Materials For Medical Uses (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
DK00983244T 1999-12-07 2000-12-07 Oligosaccharidblanding DK1242436T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19958985A DE19958985A1 (de) 1999-12-07 1999-12-07 Oligosaccharidmischung
PCT/EP2000/012345 WO2001042263A2 (fr) 1999-12-07 2000-12-07 Melange d'oligosaccharides

Publications (1)

Publication Number Publication Date
DK1242436T3 true DK1242436T3 (da) 2005-03-14

Family

ID=7931729

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00983244T DK1242436T3 (da) 1999-12-07 2000-12-07 Oligosaccharidblanding

Country Status (20)

Country Link
US (1) US7939118B2 (fr)
EP (1) EP1242436B1 (fr)
JP (1) JP2003516412A (fr)
CN (1) CN1198624C (fr)
AT (1) ATE282626T1 (fr)
AU (1) AU782623B2 (fr)
BR (1) BR0016161A (fr)
CA (1) CA2394090C (fr)
CZ (1) CZ304817B6 (fr)
DE (2) DE19958985A1 (fr)
DK (1) DK1242436T3 (fr)
ES (1) ES2233485T3 (fr)
HK (1) HK1052438B (fr)
HU (1) HUP0203707A3 (fr)
MX (1) MXPA02005491A (fr)
NO (1) NO330050B1 (fr)
NZ (1) NZ519706A (fr)
PL (1) PL356238A1 (fr)
PT (1) PT1242436E (fr)
WO (1) WO2001042263A2 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1243273A1 (fr) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition contenant un agent prebiotique pour le traitement d'inflammation et d'activation anormal des agents immunitaires non-spécifiques
NZ515869A (en) * 2001-11-30 2003-09-26 Med Chem Ingredients Ltd Compositions and methods for animal treatment comprising gluco- and isomalto- oligosaccharides
AU2005274824A1 (en) * 2004-07-19 2006-02-23 Life Science Nutrition As NGNA compositions and methods of use
WO2006012536A2 (fr) 2004-07-22 2006-02-02 Ritter Andrew J Procedes et compositions pour le traitement de l'intolerance au lactose
EP1634599A1 (fr) * 2004-08-20 2006-03-15 N.V. Nutricia Aliment infantile à activité immunostimulatrice
AU2006215603A1 (en) 2005-02-21 2006-08-24 Nestec S.A. Oligosaccharide mixture
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
EP1776877A1 (fr) * 2005-10-21 2007-04-25 N.V. Nutricia Méthode de stimulation de la flore intestinale
WO2007090894A1 (fr) 2006-02-10 2007-08-16 Nestec S.A. Melange d'oligosaccharides
MY149913A (en) * 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture
WO2007114683A1 (fr) 2006-03-30 2007-10-11 N.V. Nutricia Oligosaccharides de lait destinés à stimuler le système immunitaire
EP1974743A1 (fr) * 2007-03-28 2008-10-01 Nestec S.A. Probiotiques pour l'amélioration du microbiote intestinal
AU2008267279B2 (en) * 2007-06-25 2014-02-27 Dsm Ip Assets B.V. Novel prebiotics
AU2008324105B2 (en) * 2007-11-08 2014-01-30 Société des Produits Nestlé S.A. Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates
EP2143341A1 (fr) * 2008-07-08 2010-01-13 Nestec S.A. Composition nutritionnelle contenant un mélange d'oligosaccharides
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US20100119558A1 (en) 2008-11-10 2010-05-13 Scandivir Ab Ngna compositions and methods of use
CN102300575A (zh) * 2008-12-02 2011-12-28 普罗莱克塔生物科学公司 人乳渗透物组合物及其制备和使用方法
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CA2752800C (fr) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Formulations prebiotiques et methodes d'utilisation
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
EP2455387A1 (fr) * 2010-11-23 2012-05-23 Nestec S.A. Mélange oligosaccharide et produit alimentaire comportant ce mélange, spécialement une formule pour enfants
MX355780B (es) 2010-12-31 2018-04-30 Abbott Lab Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal.
NZ612504A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
CA2822495C (fr) 2010-12-31 2020-12-22 Abbott Laboratories Methodes d'utilisation d'oligosaccharides du lait humain afin d'ameliorer la sante respiratoire des voies aeriennes
CN110051676A (zh) 2010-12-31 2019-07-26 雅培制药有限公司 用于调节炎症的人乳寡糖
EP2658399B2 (fr) 2010-12-31 2024-02-28 Abbott Laboratories Compositions nutritionnelles contenant des oligosaccharides et des nucléotides de lait humain pour utilisation pour le traitement et/ou la prévention d'une infection à rotavirus entérique
EP2658547A1 (fr) 2010-12-31 2013-11-06 Abbott Laboratories Méthodes visant à diminuer la fréquence de l'entérocolite nécrosante chez les nourrissons, les jeunes enfants ou les enfants à l'aide d'oligosaccharides du lait humain
CN103369974A (zh) 2010-12-31 2013-10-23 雅培制药有限公司 包含人乳低聚糖和长链多不饱和脂肪酸的营养型制剂以及其用途
US20120282350A1 (en) * 2011-05-05 2012-11-08 Life Science Nutrition As Performance enhancing compositions and methods of use
EP2526784A1 (fr) 2011-05-24 2012-11-28 Nestec S.A. Composition d'oligosaccharide-galactooligosaccharide du lait pour formulation pour nourrissons contenant la fraction soluble d'oligosaccharide présente dans le lait, et disposant d'un niveau faible de monosaccharides et procédé permettant de réduire la composition
BR112014004772A2 (pt) * 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
AU2014368585A1 (en) * 2013-12-19 2016-05-19 Nestec S.A. Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants
EP3182841A1 (fr) 2014-08-18 2017-06-28 Nestec S.A. Prébiotiques pour réduire le risque d'obésité ultérieurement au cours de la vie
JP6058223B2 (ja) * 2015-01-20 2017-01-11 株式会社明治 リン吸収抑制用組成物
CN115300517A (zh) 2015-03-31 2022-11-08 格礼卡姆股份公司 包含3’-o-唾液乳糖的人乳寡糖的混合物
US10933097B1 (en) 2020-03-05 2021-03-02 King Saud University Method of treating a bacterial infection using colostrum

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859488A (en) * 1987-09-15 1989-08-22 Kabushiki Kaisha Yakult Honsha Liquid food for curing constipation: polydextrose and oligosaccharide
JP2518663B2 (ja) * 1987-12-24 1996-07-24 株式会社ヤクルト本社 ガラクトオリゴ糖含有加工乳の製造法
US5750176A (en) * 1994-03-09 1998-05-12 Abbott Laboratories Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides

Also Published As

Publication number Publication date
ES2233485T3 (es) 2005-06-16
PL356238A1 (en) 2004-06-28
US7939118B2 (en) 2011-05-10
PT1242436E (pt) 2005-04-29
CZ304817B6 (cs) 2014-11-12
BR0016161A (pt) 2002-10-29
CA2394090A1 (fr) 2001-06-14
WO2001042263A3 (fr) 2001-11-01
JP2003516412A (ja) 2003-05-13
HK1052438A1 (en) 2003-09-19
EP1242436A2 (fr) 2002-09-25
HK1052438B (zh) 2005-07-08
HUP0203707A2 (hu) 2003-03-28
CN1198624C (zh) 2005-04-27
CZ20021876A3 (cs) 2003-05-14
AU2006201A (en) 2001-06-18
HUP0203707A3 (en) 2004-12-28
DE50008706D1 (en) 2004-12-23
CA2394090C (fr) 2010-09-28
CN1407857A (zh) 2003-04-02
WO2001042263A2 (fr) 2001-06-14
DE19958985A1 (de) 2001-06-13
NO20022688L (no) 2002-06-06
NO330050B1 (no) 2011-02-07
NZ519706A (en) 2004-03-26
US20030129278A1 (en) 2003-07-10
NO20022688D0 (no) 2002-06-06
EP1242436B1 (fr) 2004-11-17
AU782623B2 (en) 2005-08-18
MXPA02005491A (es) 2002-09-02
ATE282626T1 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
DK1242436T3 (da) Oligosaccharidblanding
CA2274596A1 (fr) Compositions et procedes servant a ameliorer le fonctionnement gastro-intestinal
PT1053256E (pt) Anticorpos para o receptor de morte 4 (dr4) e utilizações destes
ATE246455T1 (de) Kohlenhydratmischung
ATE287732T1 (de) Retrovirale vektoren, die von gegen lyse durch menschliches serum resistenten produktionszellinien produziert werden
EP0950708A3 (fr) Peptides se liant à l'hyaluronane avec une affinité augmentée
UA48245C2 (uk) ЗАМІЩЕНІ 1,2,3,4-ТЕТРАГІДРО-2-ДИБЕНЗОФУРАНАМІНИ ТА 2-АМІНОЦИКЛОГЕПТА[B]БЕНЗОФУРАНИ, ФАРМАЦЕВТИЧНА ЛІКАРСЬКА ФОРМА ТА СПОСІБ ПІДВИЩЕННЯ АКТИВАЦІЇ 5-НТ<sub>1F</sub> РЕЦЕПТОРА У ССАВЦЯ
WO1999051617A3 (fr) 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-(β-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE FORME VI
ES2192889T3 (es) Agentes insecticidas.
MD980129A (en) Antiherpetic remedy
DE69729443D1 (de) Modifiziertes pektinmaterial
Ber Remarks to the articles of V. V. Teleshov
TAMURA et al. The Validity of the Workload Evaluation by Driver's Subjective Symptoms
Dugas Évolution de l’hagiotoponymie municipale québécoise (1980-87)
Mahler Fertility in some Nepali villages varies with level of gender equality
Hatcher Managing risk- the way ahead
Kim The methods of drive and approach of standardization
葛宝祥 et al. The Changes in Chinese Educational System From 1964 to 1980s
Carleton " Not one, but... so entwined": man and nature in the early poetry of Yvor Winters
Kriesel Differences of the reconstructed stature in an early Medieval population depending on Pearson's regression equations
IT1303293B1 (it) Apparecchiatura per il prelievo e l'introduzione in stie e simili diavicoli in genere.
RU96102188A (ru) Сбор n 3 лекарственных трав, обладающий общеукрепляющим действием
허원실 et al. Hemicoronal and temporal flap incision combined with intraoral approach for the zygoma fracture
SE9403791L (sv) Skida
清水秀昭 CONNECTIONS OF THE INSULAR CORTEX IN KITTENS: AN ANATOMICALDEMONSTRATION WITH WHEAT GERM AGGLUTININ CONJUGATED TO HORSERADISH PEROXIDASE TECHNIQUE